PT1014951E - Composicao de revestimento farmaceutica e metodo para a sua utilizacao - Google Patents

Composicao de revestimento farmaceutica e metodo para a sua utilizacao

Info

Publication number
PT1014951E
PT1014951E PT98944756T PT98944756T PT1014951E PT 1014951 E PT1014951 E PT 1014951E PT 98944756 T PT98944756 T PT 98944756T PT 98944756 T PT98944756 T PT 98944756T PT 1014951 E PT1014951 E PT 1014951E
Authority
PT
Portugal
Prior art keywords
coating composition
pharmaceutical coating
surfactant
polymer
composition
Prior art date
Application number
PT98944756T
Other languages
English (en)
Inventor
Patrick S-L Wong
David E Edgren
Li Shu
Bhatti Gurdish Kaur
Dong Liang Chang
Yum Si-Hong
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of PT1014951E publication Critical patent/PT1014951E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
PT98944756T 1997-09-09 1998-09-04 Composicao de revestimento farmaceutica e metodo para a sua utilizacao PT1014951E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5826497P 1997-09-09 1997-09-09

Publications (1)

Publication Number Publication Date
PT1014951E true PT1014951E (pt) 2005-03-31

Family

ID=22015721

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98944756T PT1014951E (pt) 1997-09-09 1998-09-04 Composicao de revestimento farmaceutica e metodo para a sua utilizacao

Country Status (10)

Country Link
US (1) US7087243B2 (pt)
EP (1) EP1014951B1 (pt)
JP (1) JP2001515855A (pt)
AT (1) ATE282407T1 (pt)
AU (1) AU9221898A (pt)
DE (1) DE69827650T2 (pt)
ES (1) ES2232021T3 (pt)
HK (1) HK1029277A1 (pt)
PT (1) PT1014951E (pt)
WO (1) WO1999012526A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
CA2533150C (en) * 2003-07-25 2013-03-12 Warner Chilcott Company, Inc. A doxycycline metal complex in a solid dosage form
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US8080062B2 (en) * 2008-12-02 2011-12-20 Warsaw Orthopedic, Inc. Intervertebral implant with fixation mechanism
US8814912B2 (en) 2012-07-27 2014-08-26 Zimmer Spine, Inc. Bone stabilization member with bone screw retention mechanism

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3919436A (en) * 1971-09-27 1975-11-11 Eisai Co Ltd Process for preparation of coated medicines
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
JPS5157813A (en) * 1974-11-14 1976-05-20 Sankyo Co Ll dooba mataha sonojudotaiseizaino seiho
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4117182A (en) * 1976-12-23 1978-09-26 Commercial Decal, Inc. Heat release layer for decalcomanias
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4217725A (en) * 1978-10-16 1980-08-19 Mattel, Inc. Combination doll and accessory articles
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4329451A (en) 1980-11-03 1982-05-11 The Dow Chemical Company Preparing an aqueous dispersion of colloidal size particles of a water-insoluble polysaccharide derivative
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
US5126146A (en) * 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
EP0459516A1 (en) * 1990-06-01 1991-12-04 Kirin-Amgen, Inc. Oral dosage form of biologically active proteins
GB2258810B (en) * 1991-08-12 1996-01-31 Euro Celtique Sa Pharmaceutical combination formulation of diltiazem and hydrochlorothiazide
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
GB2258613B (en) * 1991-08-12 1996-01-10 Euro Celtique Sa Pharmaceutical diltiazem formulation
ES2149250T3 (es) 1993-04-23 2000-11-01 Novartis Ag Dispositivo para la administracion de medicamentos con liberacion controlada.
WO1995001155A1 (en) * 1993-07-01 1995-01-12 Unilever N.V. Oral compositions
KR100210509B1 (ko) * 1996-01-10 1999-07-15 성재갑 지속성 동물 성장 호르몬 제형 및 이의 제조 방법

Also Published As

Publication number Publication date
JP2001515855A (ja) 2001-09-25
US20050003006A1 (en) 2005-01-06
DE69827650T2 (de) 2005-11-03
ATE282407T1 (de) 2004-12-15
US7087243B2 (en) 2006-08-08
EP1014951B1 (en) 2004-11-17
WO1999012526A1 (en) 1999-03-18
AU9221898A (en) 1999-03-29
ES2232021T3 (es) 2005-05-16
DE69827650D1 (de) 2004-12-23
HK1029277A1 (en) 2001-03-30
EP1014951A1 (en) 2000-07-05

Similar Documents

Publication Publication Date Title
BR9607862A (pt) Composição farmacêutica filmogênica para administração transdérmica
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
EE9700194A (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja NSAID
DE69525148D1 (de) Pharmazeutische formulierung
PT861666E (pt) Composicao farmaceutica para utilizacao no tratamento da diabetes
DE69801045D1 (de) Pharmazeutische zusammensetzung zur oralen verabreichung von einem n-piperidin-3-pyrazolcarboxamid-derivat, dessen salzen und deren solvaten
ITRM940621A0 (it) "composizione farmaceutica stabilizzata, relativo solvente e procedimento di preparazione"
BR9611367A (pt) Formulação farmacêutic liofilizada estável
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
EE9700195A (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja prokineetilist ainet
ATE292453T1 (de) Antivirale arznei
AR012376A1 (es) Formulacion de gel para la aplicacion topica
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
DK1112060T3 (da) Doseringsform anvendende flydende formulering
BR9506106A (pt) Composto processo para sua preparação medicamento e composição farmacêutica
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
PT101444A (pt) Associacao sinergizante com efeito antagonista dos receptores nk1 e nk2, uso de produtos com actividade antagonista dos receptores nk1 e nk2 na sua preparacao e composicao farmaceutica contendo a referida associacao
LV12250A (lv) Farmaceitiskas kompozicijas uz diklofenaka bazes
PT1014951E (pt) Composicao de revestimento farmaceutica e metodo para a sua utilizacao
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
HRP20000781B1 (en) Effervescent preparations
SE0001916D0 (sv) Novel formulation